| Property | Value |
|---|
|
?:abstract
|
-
The idea of \'what the market will bear\' has grown without bounds, since patients with good health insurance coverage have little to no sensitivity to price increases Novel infections threaten population health and economy in ways similar to or far more significantly than the threat of wars [ ]establishing a different pathway to at least some of the lifesaving vaccines and therapies has strong merit Compounding the concern that market forces to control drug prices have nearly vanished, another major issue looms large: US (and international) patent law confers 20-plus years of market exclusivity before drugs and vaccines can be manufactured competitively as generic alternatives
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
-
Issues_in_Science_and_Technology
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:source
|
|
|
?:title
|
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}